REVIEW A centrally acting reversible acetylcholinesterase inhibitor. The main therapeutic use is in the palliative treatment of mild to moderate Alzheimer's disease.
Myhrer T, Enger S, Aas P (2010). Behavioral side effects in rats treated with acetylcholinesterase inhibitors suggested used as prophylactics against nerve agents. Pharmacol Biochem Behav. 95(3):338-43. PMID 20184916.